Novel lipid-lowering agents

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Lipid-lowering drugs are the second most commonly prescribed medication class in the USA with statins being the most commonly prescribed agent within this class. The widespread use of statins owes to overwhelming evidence of benefit and safety as well as awareness campaigns directed at both the physicians and consumers.

Original languageEnglish (US)
Title of host publicationDyslipidemias: Pathophysiology, Evaluation and Management
PublisherHumana Press Inc.
Pages499-519
Number of pages21
ISBN (Print)9781607614241, 9781607614234
DOIs
StatePublished - Jan 1 2015

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Novel lipid-lowering agents'. Together they form a unique fingerprint.

  • Cite this

    Ahmad, Z., & Garg, A. (2015). Novel lipid-lowering agents. In Dyslipidemias: Pathophysiology, Evaluation and Management (pp. 499-519). Humana Press Inc.. https://doi.org/10.1007/978-1-60761-424-1_30